| Literature DB >> 28487674 |
Rachana Singh1, Parul Parihar1, Madhulika Singh1, Andrzej Bajguz2, Jitendra Kumar1, Samiksha Singh1, Vijay P Singh3, Sheo M Prasad1.
Abstract
Cyanobacteria and algae having complex photosynthetic systems can channelize absorbed solar energy into other forms of energy for production of food and metabolites. In addition, they are promising biocatalysts and can be used in the field of "white biotechnology" for enhancing the sustainable production of food, metabolites, and green energy sources such as biodiesel. In this review, an endeavor has been made to uncover the significance of various metabolites like phenolics, phytoene/terpenoids, phytols, sterols, free fatty acids, photoprotective compounds (MAAs, scytonemin, carotenoids, polysaccharides, halogenated compounds, etc.), phytohormones, cyanotoxins, biocides (algaecides, herbicides, and insecticides) etc. Apart from this, the importance of these metabolites as antibiotics, immunosuppressant, anticancer, antiviral, anti-inflammatory agent has also been discussed. Metabolites obtained from cyanobacteria and algae have several biotechnological, industrial, pharmaceutical, and cosmetic uses which have also been discussed in this review along with the emerging technology of their harvesting for enhancing the production of compounds like bioethanol, biofuel etc. at commercial level. In later sections, we have discussed genetically modified organisms and metabolite production from them. We have also briefly discussed the concept of bioprocessing highlighting the functioning of companies engaged in metabolites production as well as their cost effectiveness and challenges that are being addressed by these companies.Entities:
Keywords: algae; biofuel; cyanobacteria; cyanotoxins; food products; pharmaceuticals
Year: 2017 PMID: 28487674 PMCID: PMC5403934 DOI: 10.3389/fmicb.2017.00515
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Main pathways for the biosynthesis of some secondary as well-primary (carbohydrate, starch, alcohol, etc.) metabolites in eukaryote (❶) and prokaryote (❷) (modified after Burja et al., 2001; Oliver et al., 2016).
Figure 2Chemical structures and significance of polyphenols: (A) cinamic acid, (B) hydroxy-benzoic acid, (C) flavonoids, (D) lignans, and (E) tocopherols obtained from different cyanobacteria and algae.
An overview of metabolites from cyanobacteria and algae and their potential uses.
| Phenolic compounds |
Potentially considered for pharmaceutical and nutritional uses (for example as additive in the preparation of functional food). Prevents vascular damage as well as cardiovascular diseases progression. Provides defense by scavenging the free radicals. Acts as a UV-B screening compound, provide resistance to plants against pathogens, pests, and diseases. | Rice-Evans et al., | |
| Fatty acids |
Highly potent to be used as liquid transport fuels. Consume as in diet due to high content of polyunsaturated fatty acid, protein, and vitamins. Provides chemical defense as it is toxic to grazers. Lipid extracts may be used as a herbal medicine, to treat against cancer, viruses, burns, and chronic fatigue. | Anupama and Ravindra, | |
| Terpenoids |
Highly potent to be used as hydrocarbon biofuel. Provides chemical defense against herbivory, fragrances, and flavors. | Kirby and Keasling, | |
| Mycosporine-glycine, Porphyra-334, Shinorine |
Provides protection against UV-B, high temperature, and photooxidative stress. Acts as osmolytes and improves antioxidant status, which subsequently lowers the level of ROS. | Oren and Gunde-Cimerman, | |
| Carotenoids, β-Carotene, Lutein, Zeaxanthin, Cryptoxanthin, α-carotene, Lycopene |
Protects PSII, light harvesting complexes, and reaction center. Improve antioxidant status of the organisms. Use in food industry. Use to prevent cancer. | Cardozo et al., | |
| Scytonemin |
Having an unique pharmacological potential and used as anti-inflammatory and antiproliferative agent. | Stevenson et al., | |
| Carragenans, Agar, and Lectins |
Widely used as antitumor, antiviral, anticoagulant, and immunomodulation agent. Used as a vehicle to deliver drugs. | Marinho-Soriano and Bourret, | |
| Halogenated compounds |
Exhibit antiviral, antifungal, antifouling, antiproliferative, antibacterial, anti-inflammatory activity. Show cytotoxic, antifeedant, insecticidal, and ichthyotoxic responses. | Blunt et al., | |
| Phytohormones |
Promote growth and development, enhances the production of ethylene that may be used as biofuel. Enhanced the production of defense enzymes and provide protection against different stresses. | Takahama et al., | |
| Toxins |
Used for development of biocides that serve as antibiotics, anticancerous, and anti-inflammatory agents with relevant to pharmaceutical activities. | Burja et al., |
Organisms that are eukaryotic algae are designated with “.
Figure 3Chemical structures and significance of terpenoid/ phytoene: (A) ubiquinone, (B) ergosterol, (C) phytol, and (D) lutein obtained from different cyanobacteria and algae.
Figure 4Chemical structures and significance of photoprotective compounds: (A) asterina-330, (B) mycosporine-glycine, (C) palythine, (D) palythinol, (E) porphyra-334, (F) shinorine, (G) β-carotene, (H) astaxanthin, and (I) scytonemin obtained from different cyanobacteria and algae.
Figure 5Chemical structures and significance of phycocolloid compound: (A) carrageenan, (B) agar, and (C) alginate polymer obtained from different cyanobacteria and algae.
Figure 6Chemical structures and significance of halogenated compound: (A) bromoanaindolone, (B) plocoralide A, (C) grenadamides B, (D) grenadamides C, and (E) 3-bromo-nanonoic acid polymer obtained from different cyanobacteria and algae.
An overview of various phytohormones produced by algae and their potential implication in microbial biotechnology.
| Abscisic acid (ABA) | Exogenous ABA decreases growth rate in | Improvement in stress tolerance. | Boyer and Dougherty, | |
| Auxins | Exogenous indole-3-acetic acid (IAA) improves growth rate in | Elevation of microalgal growth rate, biomass production, oil content, and stress tolerance. | Ashen et al., | |
| Cytokinins (CK) | Exogenous CK improves cell cycle progression in | Elevation of microalgal growth rate, oil content, and stress tolerance. | Jennings, | |
| Ethylene (ET) | ET take part in programmed cell death of microalgae in | Enhancement of microalgal growth rate as well as biomass productivity. | Watanabe and Kondo, | |
| Gibberellins (GA) | Exogenous GA stimulates astaxanthin biosynthesis in | Increased algal growth rate and biomass productivity. Target chemical production. | Jennings, |
Organisms that are eukaryotic algae are designated with “.
Figure 7Chemical structures of cyanotoxins: (A) microcystin-LR, (B) nodularin, (C) saxitoxin (D) anatoxin- a, and (E) cylinderosprmopsin obtained from different cyanobacteria.
An overview of cyanotoxins produced by algae and cyanobacteria and their potential impacts on other organisms.
| Cylindrosper-mopsins (Hepatotoxic, nephrotoxic, and cytotoxic) | Guanidine alkaloid | Inhibitor of protein biosynthesis, glutathione synthesis, implicate cytochrome P-450, overexpression of DNA damage repair proteins genotoxic. | Humpage et al., | |
| Dermatotoxins Aplysiatoxins | Alkaloid (phenolic bislactone) | Inflammatory agents, protein kinase C activators. Dilation of the lymphatic vessel and congestion of capillaries, diarrhea, and Fibrin deposition in the dilated pulmonary artery followed by bleeding. | Fujiki et al., | |
| Lyngbyatoxin | Alkaloid | Causes erythema (dermatitis), blisters, and necrosis in mammals; potent tumor promoters. | Fujiki et al., | |
| Endotoxins Lipopolysacc-haride | All cyanobacteria | Lipopolysaccharide | Inflammatory agent, gastrointestinal irritants. | Stewart et al., |
| Hepatotoxins Heptapeptide | – | – | Metcalf and Codd, | |
| Microcystins | Cyclic heptapeptide | Inhibition of protein phosphatases (PP1 and PP2A). | Dittmann and Wiegand, | |
| Nodularin | Cyclic pentapeptide | Inhibition of protein phosphatases (PP1 and PP2A). | Bagu et al., | |
| Neurotoxins Anatoxin-a | Alkaloid | Binds irreversibly to the nicotinic acetylcholine receptors. | Namikoshi et al., | |
| Anatoxin-a (s) | Guanidine methyl | Inhibits acetylcholinesterase activity. | Matsunaga et al., | |
| β- | phosphate ester | Causes disorder of Motor system, glutamate agonist, increasing the intracellular concentration of calcium in neurons and inducing neuronal activity by hyperexcitation. | Lobner et al., | |
| Cyanopeptolin | – | Transcriptional alterations of genes belonging to DNA damage and repair. | Faltermann et al., | |
| Saxitoxins | Carbamate alkaloid | Binds and blocks the sodium channels in neural cells. | Strichartz et al., | |
| Other toxins Debromoaplysiat-oxin | Polyacetates | Tumor promoters. | Fujiki et al., | |
| Kalkitoxin | Lipopeptide | Block the sodium channels of nerve cell. | Edwards et al., |
Organisms that are eukaryotic algae are designated with “.
Figure 8Processes of biodiesel and bioethanol production from microalgae (modified from Dragone et al., .
Various therapeutic agents produced by cyanobacteria and algae and their potential uses.
| Acetylated sulfoglyco-lipids | Antiviral | Reshef et al., | |
| Acutiphycin | Anticancer | Barchi et al., | |
| Aeruginosins | Serine proteases inhibitor | Shin et al., | |
| Agardhipeptin | Enzyme inhibitor | Luukkainen et al., | |
| Alkaloids (ambiguine H & I isonitriles) | Antibacterial | Raveh and Carmeli, | |
| Allophycocyanin | Cryptomonads* | Enterovirus 71 | Shih et al., |
| Ambigol A, B | antifungal, antibacterial | Falch et al., | |
| Ambiguine I isonitrile | Antibacterial | Raveh and Carmeli, | |
| Anatoxin-a | Larvicide | Berry et al., | |
| Anatoxin-a | Inflammatory | Rajeev and Xu, | |
| Anhydrohapaloxindole | Antifungal | Moore et al., | |
| Ankaraholide A | Anticancer | Mynderse et al., | |
| Aplysiatoxin | Anticancer | Andrianasolo et al., | |
| Aponin | Antialgal | Bhadury and Wright, | |
| Apratoxin A | Anticancer | Andrianasolo et al., | |
| Apratoxins B–C | Anticancer | Luesch et al., | |
| Apratoxin D | Anticancer | Gutierrez et al., | |
| Apratoxin E | Anticancer | Matthew et al., | |
| Apratoxins F and G | Anticancer | Tidgewell et al., | |
| Aurilide B | Anticancer | Han et al., | |
| Aurilide C | Anticancer | Han et al., | |
| Bastadin | Antibiotic | Miao et al., | |
| Bauerines A–C | Anti-Herpes simplex virus type 2 (HIV-2) | Larsen et al., | |
| Belamide A | Antibiotic | Ma and Led, | |
| Bis-(χ-butyrolactones) | Anticancer | Simmons et al., | |
| Bisebromoamide | Anticancer | Teruya et al., | |
| Biselyngbyaside | Anticancer | Teruya et al., | |
| Borophycin | Anticancer | Hemscheidt et al., | |
| BP-1 Thermostable polyphosphate kinase | Production of dipeptides | Sato et al., | |
| Butanoic acid and Methyl lactate | Antibacterial | Santoyo et al., | |
| Calcium spirulan | Antiviral (Anti-(HIV) Human Immunodeficiency Virus) | Hayashi et al., | |
| Calophycin | Fungicide | Moon et al., | |
| Calothrixins A,B | Antimalarial, anticancer | Bernardo et al., | |
| Carazostatin | Antifungal | Burja et al., | |
| Carbamidocyclophanes A-E | Antibiotic and cytotoxic | Bui et al., | |
| Carmabin A,B | Antimalarial, anticancer, antiproliferative | McPhail et al., | |
| Caylobolide A | Anticancer | MacMillan and Molinski, | |
| Caylobolide B | Anticancer | Salvador et al., | |
| Circinamide | Enzyme inhibitor | Negri and Jones, | |
| Coibamide A | Anticancer | Medina et al., | |
| Cryptophycins | Anticancer | Moore et al., | |
| Curacin A | Anticancer | Simmons et al., | |
| Curacin A | Microtubulin assembly inhibitors | Shimizu, | |
| Cyanobactericin | Antialgal | Abarzua et al., | |
| Cyanobacterin LU-1 | Antialgal | Gromov et al., | |
| Cyanovirin -N | Anti-HIV, antiviral | Dey et al., | |
| Cyclic polypeptide | Anti-HIV activity | Rajeev and Xu, | |
| Cylindrospermopsin | Larvicide | Berry et al., | |
| Debromoaplysiatoxin | Inflammatory | Shimizu, | |
| Didehydromirabazole | Antibiotic | Stewart et al., | |
| Diterpenoid | Antibacterial | Asthana et al., | |
| Dolastatins | Antimalarials, anticancer | Fennell et al., | |
| Dragonamide A, B | Antimalarial | McPhail et al., | |
| Dragonamide C, D | Anticancer | Gunasekera et al., | |
| Eicosapentaenoic acid | Antibacterial | Smith et al., | |
| Ester | Antibacterial | Findlay and Patil, | |
| Ethyl Tumonoate A | Anticancer | Engene et al., | |
| Extracellular sulfated polysaccharides | Influenza virus A and B, RSV A and B, and HSV-1 | Hasui et al., | |
| Fatty acids (coriolic acid and α-dimorphecolic acid | Antibacterial | Mundt et al., | |
| Fischambiguine B | Antibacterial | Mo et al., | |
| Fischerindole L | Antifungal | Park et al., | |
| Fisherellin | Antialgal, antifungal | Dahms et al., | |
| Galactosyldiacylglycerols | Antialgal, anti-HIV | Rajeev and Xu, | |
| Gambieric acids A and B | Antifungal | Bhadury and Wright, | |
| γ- linolenic acid | Predecessor of arachidonic acid | Cohen, | |
| Grassypeptolide | Antiproliferative | Kwan et al., | |
| γ-linolenic acid | Antibacterial | Asthana et al., | |
| Goniodomin A | Antifungal | Bhadury and Wright, | |
| Hapalindole | Antifungal | Burja et al., | |
| Hierridin B | Antitumor | Leão et al., | |
| Hoiamide A | Assemblage of | Anticancer | Choi et al., |
| Hoiamide B | Cyanobacterial sample | Anticancer | Choi et al., |
| Homodolastatin 16 | Anticancer | Davies-Coleman et al., | |
| Hormothamnins | Antibacterial, antifungal | Gerwick et al., | |
| Ichthyopeptins A and B | Antiviral | Zainuddin et al., | |
| Indolocarbazoles | Antiviral | Cohen, | |
| Isomalyngamide A and A-1 | Anticancer | Chang et al., | |
| Kaempherol | Anticancer | Al-Saif et al., | |
| Kalkitoxin | Sodium channel blocker | Shimizu, | |
| Karatungiols | Antifungal | Washida et al., | |
| δ-lactone malyngolide | Antibacterial | Cardllina et al., | |
| Kawaguchipeptin B | Antibacterial | Dahms et al., | |
| Lagunamide C | Anticancer | Tripathi et al., | |
| Largazole | Anticancer | Zeng et al., | |
| Laxaphycins | Antifungal | Frankmölle et al., | |
| Lyngbyastatin | Serine protease inhibitor | Matthew et al., | |
| Lyngbyatoxins | PKC activator | Shimizu, | |
| Majusculamide C | Anticancer | Pettit et al., | |
| Malevamide D | Anticancer | Horgen et al., | |
| Malyngamide 2 | Anticancer | Malloy et al., | |
| Methanolic and hexanolic extracts | Antibacterial | Ghasemi et al., | |
| Microcystin | Algicide/larvicide/herbicide | Berry et al., | |
| Muscoride | Antibiotic | Nagatsu et al., | |
| Muscoride A | Antibacterial | Nagatsu et al., | |
| Naienones A-C | Antitumoural | Nagle and Gerwick, | |
| Norharmane | Antibacterial | Volk and Furkert, | |
| Noscomin | Antibacterial | Jaki et al., | |
| Nostocarboline | Antimalarial, antileishmaniasis, cholinesterase inhibitor | Barbaras et al., | |
| Nostocine A | Antibiotic | Hirata et al., | |
| Nostocyclamide | Antifungal | Moore et al., | |
| Nostocycline A | Antibacterial | Ploutno and Carmeli, | |
| Nostodione | Antifungal | Bhadury and Wright, | |
| Nostoflan | Antiviral | Hayashi et al., | |
| p-KG03exopolysaccharide | Encephalomyocarditis virus | Yim et al., | |
| Pahayokolides | Antialgal/larvicidal | Gantar et al., | |
| Parsiguine | Antibacterial | Ghasemi et al., | |
| Peptide | Antibacterial | Berland et al., | |
| Antibacterial | Sieburth, | ||
| Pheophorbide α-,β-like compounds | HSV-1 | Ohta et al., | |
| Palmyramide A | Anticancer | Taniguchi et al., | |
| Phytoalexin | Antifungal | Patterson and Bolis, | |
| Pitipeptolides C | Anticancer | Montaser et al., | |
| Pitiprolamide | Anticancer | Montaser et al., | |
| Polysaccharide | HSV-1 and -2, Influenza A virus | Lee et al., | |
| Polyether compounds | Antifungal | Bhadury and Wright, | |
| Quercetin | Antifungal | Al-Saif et al., | |
| Radiosumin | Enzyme inhibitor | Mooberry et al., | |
| Rutin | Enzyme inhibitor | Al-Saif et al., | |
| Schizotrin A | Antifungal, antibacterial | Pergament and Carmeli, | |
| Scytophycins | Antifungal | Burja et al., | |
| Scytophycins | Antifungal | Ishibashi et al., | |
| Scytoscalarol | Antibacterial | Mo et al., | |
| Scytovirin | Anti-HIV activity | Bokesch et al., | |
| Somocystinamide A | Anticancer | Wrasidlo et al., | |
| Spirulan | Antiviral | Hayashi et al., | |
| Sulfolipids | Anti-HIV activity | Rajeev and Xu, | |
| Sulfated polysaccharides | Viral hemorrhagic septicemia virus, African swine fever virus | Fábregas et al., | |
| Symplocamide A | Antimalarial, antileishmaniasis, anticancer | Linington et al., | |
| Symplostatin 3 | Anticancer | Luesch et al., | |
| Tanikolide | Antifungal | Singh et al., | |
| Tenuecyclamides | Antibacterial and cytotoxic | Banker and Carmeli, | |
| Thermostable enzymes | Catalysis of reactions | Piechula et al., | |
| Tjipanazoles | Anticancer | Bonjouklian et al., | |
| Tolybyssidins | Antifungal | Jaki et al., | |
| Tolyporphin | Antibiotic | Prinsep et al., | |
| Tolytoxin | Antifungal | Patterson and Carmeli, | |
| Toyocamycin | Antifungal | Banker and Carmeli, | |
| Tubercidin toyocamycin | Fungicidal, cytotoxic | Stewart et al., | |
| Venturamide A,B | Antimalarial | Linington et al., | |
| Veraguamides A-G | Anticancer | Mevers et al., | |
| Wewakazole | Anticancer | Malloy et al., | |
| Wewakpeptins | Anticancer | Han et al., |
Organisms that are eukaryotic algae are designated with “.